HO CHI MINH CITY, VIETNAM--(Marketwire - Dec 5, 2012) - Health Sciences Group, Inc. (PINKSHEETS: [ HESG ]) today announced that it has entered the highly sought-after and lucrative healthcare mobile apps for the medical marijuana industry. In addition, the Company is in talks to acquire a California-based cannabis dispensary to further expand its products and services and utilizing this facility as a stepping stone to develop its first medical marijuana apps for the Android and iPhone users. Concurrently, management has decided to relocate headquarters and software development center to the youthful and vibrant city of Ho Chi Minh City, Vietnam to attract its local dynamic workforce.

Management believes mobile apps developers from Vietnam and China have been playing a dominant role in designing and developing some of the world's finest mobile applications. With many social media sites coming out on a regular basis, mobile apps programming will lend itself as a must-have and complimentary tool to attract its visitors and retain logins and memberships.

"We're delighted to be a part of the game-changing world of healthcare mobile apps development for the newly-sought after field of medical marijuana. Vietnam is our perfect choice to attract such talent and reasonable wages the area has to offer. With our cost cutting and reduced overhead expenses, HESG will quickly be in positive territory for several immediate acquisitions," stated Mr. Robinson To, Chief Executive Officer.

"With that in mind, I would like to draw your attention to our new website HESciencesGroup.com. This site will serve as the central hub for all business units as well as communication link between our investors and management," continued Mr. To.

Management has also committed to keep the current shares structure without any reverse splits now or anytime in the future. Additionally, cost cutting and shares reducing will be on top of management's priority list.

About Health Sciences Group, Inc.

Health Sciences Group, Inc. is an investment technology portfolio company that acquires nascent health sciences technology and related innovations, inventions and IP assets to enhance their growth and development. The company builds revenues and asset value through a model of continuous growth, income from or sale of its portfolio holdings, and technology licensing or distribution agreements.

This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the company and its management team. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management's control. Some of these factors include the ability of the company to raise sufficient capital, attract qualified management, attract new customers and effectively compete against similar companies.